Original Articles |
From the Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Scottsdale, Ariz (K.S.S.), and Rochester, Minn (T.J.B., S.J.A., P.A.F., T.M.M., S.C.H., Y.-M.C., P.A.B., A.J., D.J.B., R.F.R., D.L.P., W.-K.S.), and the Division of Anatomic Pathology, Mayo Clinic, Rochester, Minn (W.D.E.).
Correspondence to Win K. Shen, MD, Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905. E-mail wshen{at}mayo.edu
Received November 3, 2007; accepted December 24, 2007.
| Abstract |
|---|
|
|
|---|
Methods and Results— Twelve patients with outflow tract ventricular arrhythmia originating above the semilunar valves with discrete arterial potentials were studied. The clinical characteristics, properties of the arterial potentials, electrophysiological evaluation and ablation, and short- and long-term outcomes were reviewed. Of the twelve patients, 8 (67%) were women. The patients average age was 41±14 years. The average ejection fraction was 0.52±0.16 (range: 0.16 to 0.75). Contact mapping in the great artery demonstrated discrete near-field electrograms that were separate from far-field ventricular electrograms in all patients (8 above the pulmonary valve and in 4 the aortic valve). One or more of the following electrophysiological characteristics, supportive of an arrhythmogenic substrate, were observed in 10 of 12 patients: (1) A fixed or reproducibly variable pattern of discrete potential–ventricular arrhythmia relationship was present at baseline or during pacing; (2) the discrete potential–ventricular electrogram relationship during sinus rhythm was the reverse of that during the ventricular arrhythmia; (3) during sustained ventricular tachycardia, spontaneous variation of the ventricular (V-V) cycle length was preceded by a similar variation of arterial spike potential–spike potential cycle length; and (4) ablation guided by the discrete arterial potential successfully eliminated the clinical arrhythmia. Ablation was successful in these patients. In the remaining 2 patients, the potentials were believed to be bystanders. Over 10±4 months (range: 5 to 32 months) of follow-up, there have been no recurrences of the premature ventricular complex or ventricular arrhythmia.
Conclusions— Discrete potentials are present in the great arteries of a select group of patients with outflow tract ventricular tachycardia originating above the semilunar valves. When an arrhythmogenic relationship can be demonstrated, discrete potentials are useful in guiding ablation within the great vessels, despite significant anatomic complexity.
Key Words: arrhythmias, cardiac, ventricular aorta tachycardia, ventricular pulmonary artery electrophysiology catheter ablation, radiofrequency
| Introduction |
|---|
|
|
|---|
10% of patients referred for evaluation of VT.1 In this subset of patients, outflow tract VT is the most common form. This type of VT typically arises below the semilunar valves in the region of the right or left ventricular outflow tracts, along multiple sites of the septum, near the His bundle, and on the epicardial surface of the ventricles.2–10 VT originating above the level of the semilunar valves has also been described in a small number of case studies.4–8,11–14 Ventricular myocardium extends up to the semilunar valves and is circumferential in the pulmonary root but incomplete in the aorta because of the intervalvular fibrosa.15,16 Recent studies have shown that ventricular myocardial extensions extend into the pulmonary artery and aorta beyond the semilunar valves.17,18 Ventricular myocardium extending into the great vessels above the semilunar valves may be a trigger for the arrhythmia, similar to that observed from the superior vena cava and pulmonary veins in patients with atrial fibrillation.12,19
Radiofrequency ablation is a highly successful means to treat outflow tract VT.3,20,21 Prior studies have typically involved patients in whom the VT was triggered from sites below the semilunar valves. Less is known about treatment and mapping of idiopathic outflow tract VT originating above the semilunar valves.
| Methods |
|---|
|
|
|---|
Diagnosis of Discrete Potentials
Bipolar recordings were filtered at 30 to 500 Hz. Discrete sharp electrograms separated from far-field ventricular electrograms by an isoelectric period were considered discrete potentials. The presence of such potentials, as well as the extent of the isoelectric period between ventricular and atrial activation in sinus rhythm and atrial and ventricular pacing, was noted. The site at which these electrograms were recognized was further localized with fluoroscopic and intracardiac ultrasound data. When intracardiac ultrasound was available, the distances from the potential to the semilunar valves were noted. The relationship of the potentials in the great arteries and the QRS complex/local ventricular electrograms during premature beats and other ventricular arrhythmia was noted. Pace mapping data from these sites were collected.
Mapping Technique
Deflectable electrophysiological catheters (EP Technologies, Biosense Webster) were advanced via the femoral veins to map the right ventricular outflow tract. A retrograde transaortic approach was used to map the left ventricular outflow tract. The catheters were guided with fluoroscopy and intracardiac ultrasound. Point-to-point mapping identified the earliest site of origin for the ectopic beats or VT. The exact anatomic site with reference to the semilunar valve and coronary arteries was noted with either intracardiac ultrasound or coronary angiography.
Electroanatomic Mapping
The CARTO System (Biosense Webster, Johnson & Johnson, Diamond Bar, Calif) was used with standard techniques22 in cases in which frequent ventricular arrhythmias (spontaneous or induced) were present to aid accurate localization and to allow redeployment of a catheter to a site of good pace mapping or early electrogram during arrhythmia.
Noncontact Mapping
In 2 cases, standard techniques of noncontact mapping (Endocardial Solutions, St. Paul, Minn) were used, with a multielectrode array placed in the right ventricular outflow tract. The technique was as described elsewhere.23 In these cases, either the VT was unstable, or rare premature beats were noted during the electrophysiological study.
Intracardiac Ultrasound
A linear phased-array probe was placed in the right atrium, tricuspid annulus, or the right ventricular outflow tract via the right femoral vein. A 10-French or 8-French catheter with bidirectional deflection was used (Acuson Siemens Corp, Mountain View, Calif). Ultrasound imaging was used to exclude aortic arch thrombus/debris, identify the location of the semilunar valve in relation to the ablation catheter (Figure 1), and estimate proximity of the ostia of the main coronary arteries to the ablation catheter.
|
Ablation was performed by delivering radiofrequency energy with a standard deflectable 4- or 5-mm-tip ablation catheter. The output was adjusted to between 5 and 50 W to achieve a target temperature of 45 to 60°C. When the ablation site was near a coronary artery origin (between 5 and 20 mm), energy was started at low output (5 to 10 W) and titrated upward according to the catheter tip temperature and patients clinical response, such as chest pain or hemodynamic or electrocardiographic changes.
| Results |
|---|
|
|
|---|
|
|
At baseline, we observed 2 patterns to describe these potentials:
|
|
|
|
|
|
|
Before ablation in the aortic cusp, angiography was performed to determine the relative distance between the catheter tip and the coronary artery (Figure 2). Two patients required linear ablation to successfully treat the arrhythmia. In the first patient, segmental isolation of the aorta was successfully performed, rather than focal ablation, because of the proximity of the left main artery (<5 mm) to the targeted site. In this case, circumferential ablation and ultimately isolation of the aorta and left ventricle were guided by insertion of a Lasso catheter into the aortic root (Figure 2). In the second patient with multiple VTs and PVCs, point ablation above the pulmonary valve terminated one arrhythmia. A second linear ablation line was drawn along the left ventricular septum, to a scar most likely related to prior aortic valve surgery, to terminate a second distinct left ventricular outflow tract VT. In all cases, the clinical arrhythmia was noninducible or the PVC did not recur after ablation.
Periprocedural complications included a vascular access site complication in 1 patient. No stroke, cardiac perforation with tamponade, coronary arterial damage, myocardial infarction, or valvular damage was seen in any of these cases.
Long-Term Follow-Up
The patients were followed up for an average of 10±4 months (range: 5 to 32 months). The targeted PVC or VT did not recur during the follow-up period. In the 1 case in which isolation with circumferential ablation of the aortic root was performed, no evidence of stenosis was noted at 14 months follow-up by echocardiogram. During follow-up, there was no evidence of new-onset, symptomatic coronary artery disease in any of the patients.
In the subset of patients with dilated cardiomyopathy, the ejection fraction improved in 2 (ejection fraction 0.43 to 0.55, 0.45 to 0.59). The patient with a severely depressed ejection fraction of 0.16 did not improve his cardiac function or heart failure symptoms.
| Discussion |
|---|
|
|
|---|
An anatomic basis exists for the presence of these potentials. The truncus arteriosus initially arises entirely from the right ventricle, with a sleeve of myocardium separating the semilunar endocardial cushions from the atrioventricular endocardial cushions. The truncus arteriosus then divides into the aortic and pulmonary artery trunks, and an infundibular septum forms between the developing aortic and pulmonary valves. This process results in a conus with a "figure-8" orifice. Gradually, the conus beneath the aortic valve regresses to allow the aorta to shift into the left ventricle. Retention of some of this conal muscle could allow myocardium to persist up along the aortic sinus. In comparison, the pulmonary valve normally sits in a crater of myocardium, which can extend variable distances above the annular insertion of the cusps. This myocardial extension may be particularly pronounced in patients with congenital right ventricular outflow tract obstructions, hypoplastic pulmonary valves, and hypoplastic pulmonary arteries.15,24 Recently ventricular myocardial extensions have been shown in both the pulmonary artery and aorta.17,18
Foremost in the evaluation of these potentials is to separate them from the electrical signals from nearby structures such as the ventricle and atrium. This becomes particularly important when near-field and far-field signals are fused. Several maneuvers were used to delineate the origin of these potentials. For example, pacing the ventricle close to the semilunar valve but in the ventricular myocardium resulted in an earlier stimulus-to-electrogram time of the ventricular potential, with no significant effect on the near-field discrete potential. Next, the ventricle was paced at increasingly rapid rates, and the potential was seen to occur with either a similar or longer delay from the far-field ventricular electrogram. Then, pacing above the valve resulted in either capture or near-simultaneous occurrence of the pacing stimulus and the near-field great arterial electrogram. Finally, the atrium was paced with atrial capture, and no direct relationship was identified between the atrium and the discrete electrograms
We next sought to determine the relationship of these potentials and the clinical arrhythmia. This relationship was supported by a fixed or reproducibly variable pattern of the discrete potential–ventricular arrhythmia relationship at baseline or during pacing; a reversal of the discrete potential–ventricular electrogram relationship during sinus rhythm versus that during the ventricular arrhythmia; and during sustained VT, spontaneous variation of V-V cycle length being preceded by a similar variation of S-S cycle length. In the absence of inducibility of the clinical arrhythmia or spontaneous PVCs, pace mapping can provide potential evidence that the targeted site is appropriate. When attempting to perform pace mapping at a site where a discrete potential is found, it is important to pace at both high and low output. If the high and low output–generated surface QRS complexes are identical, the data do not allow a clear differentiation between the pacing and arrhythmia origin sites. If high-output pacing and low-output pacing differ in QRS morphologies and the high-output pacing morphology is similar to the clinical arrhythmia, this suggests that the ventricular myocardium at the site of pacing is responsible for the tachycardia and the discrete potential is a bystander. Conversely, if low-output pacing reproduces the clinical arrhythmia whereas capture at higher output of the surrounding myocardium does not, a "fascicular" origin for the arrhythmia can be surmised (presumably the captured arrhythmogenic fascicle exits to depolarize the myocardium with conduction delay; Figure 10).
|
Although ablation above the semilunar valves was successful, it must be viewed in the context of safety. The site of origin of these discrete potentials in the aorta was often not close enough to the coronary arterial system to prohibit ablation. Nonetheless, an angiogram is required to determine the exact distance. If there is not enough distance to provide a comfortable safety margin, we report a novel means to circumvent this problem. With insertion of a Lasso catheter in the aorta, 1 patient received segmental isolation of the aorta inferior to the coronary artery ostium. This maximized the distance from the coronary artery ostium to the catheter tip and provided acceptable efficacy.
Limitations
This study data analysis was retrospective, and not all pacing and imaging information was available in each patient in whom these potentials were found. Prospective studies that use a standardized protocol in all patients undergoing outflow tract ablation are required. The prevalence of discrete potentials in patients with clinical ventricular arrhythmias or in general originating above the semilunar valves cannot be deduced from this study because a search for discrete potentials was not routinely performed in all patients during the study period. The actual cell of origin for the discrete potential is not established from this series, and further detailed investigation is required to ascertain this. Long-term follow-up in a larger group of patients will be needed to assess the safety of ablation in the great arteries.
Conclusion
Discrete potentials above the semilunar valves in the great arteries are seen in selected patients with outflow tract tachycardia. In the majority of cases reported herein, these potentials were an arrhythmogenic source for the patients clinical arrhythmia, and targeting these potentials, either with direct ablation or by using these potentials to guide isolation of the great arterial trunks, was useful. Nevertheless, in some cases, these potentials may result from bystander tissue getting passively activated from the ventricle. The precise mechanism of these potentials and their role in the causation of arrhythmia need to be explored further.
| Acknowledgments |
|---|
Dr Packer has received research grants from Biosense Webster, Siemens Acuson, and Boston Scientific. The other authors report no potential conflicts.
| References |
|---|
|
|
|---|
2. Kamakura S, Shimizu W, Kiyotaka M, Taguchi A, Suyama K, Kurita T, Aihara N, Ohe T, Shimomura K. Localization of optimal ablation site of idiopathic ventricular tachycardia from right and left ventricular outflow tract by body surface ECG. Circulation. 1998; 98: 1525–1533.
3. Coggins D, Lee R, Sweeney J, Chein W, Van Hare G, Epstein L, Gonzalez R, Griffin J, Lesh M, Scheinman M. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol. 1994; 23: 1333–1341.[Abstract]
4. Timmermans C, Rodriguez L, Crijns H, Moorman A, Wellens H. Idiopathic left bundle-branch block–shaped ventricular tachycardia may originate above the pulmonary valve. Circulation. 2003; 108: 1960–1967.
5. Hachiya H, Aonuma K, Yamauchi Y, Igawa M, Nogami A, Iesaka Y. How to diagnose, locate, and ablate coronary cusp ventricular tachycardia. J Cardiovasc Electrophysiol. 2002; 13: 551–556.[CrossRef][Medline]
6. Kanagaratnam L, Tomassoni G, Schweikert R, Pavia S, Bash D, Beheiry S, Neibauer M, Saliba W, Chung M, Tchou P, Natale A. Ventricular tachycardias arising from the aortic sinus of Valsalva: an under-recognized variant of left outflow tract ventricular tachycardia. J Am Coll Cardiol. 2001; 37: 1408–1414.
7. Quyang F, Fotuhi P, Ho S, Hebe J, Volkmer M, Goya M, Burns M, Antz M, Ernst S, Cappato R, Kuck K. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol. 2002; 39: 500–508.
8. Tada H, Hiratsuji T, Naito S, Kurosaki K, Ueda M, Ito S, Shinbo G, Hoshizaki H, Oshima S, Nogami A, Taniguchi K. Prevalence and characteristics of idiopathic outflow tract tachycardia with QRS alternation following catheter ablation requiring additional radiofrequency ablation at a different point in the outflow tract. Pacing Clin Electrophysiol. 2004; 27: 1240–1244.[CrossRef][Medline]
9. Azegami K, Wilber DJ, Arruda M, Lin AC, Denman RA. Spatial resolution of pacemapping and activation mapping in patients with idiopathic right ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol. 2005; 16: 823–829.[CrossRef][Medline]
10. Yamauchi Y, Aonuma K, Takahashi A, Sekiguchi Y, Hachiya H, Yokoyama Y, Kumagai K, Nogami A, Iesaka Y, Isobe M. Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle. J Cardiovasc Electrophysiol. 2005; 16: 1041–1048.[CrossRef][Medline]
11. Merino J, Peinado R, Ramirez L, Echeverria I, Sobrino J. Ablation of idiopathic ventricular tachycardia by bipolar radiofrequency current application between the left aortic sinus and the left ventricle. Europace. 2000; 2: 350–354.
12. Chen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation. 1999; 100: 1879–1886.
13. Tanner H, Hindricks G, Schirdewahn P, Kobza R, Dorszewski A, Piorkowski C, Gerds-Li J-H, Kottkamp H. Outflow tract tachycardia with R/S transition in lead V3. J Am Coll Cardiol. 2005; 45: 418–423.
14. Sekiguchi Y, Aonuma K, Takahashi A, Yamauchi Y, Hachiya H, Yokoyama Y, Iesaka Y, Isobe M. Electrocardiographic and electrophysiologic characteristics of ventricular tachycardia originating within the pulmonary artery. J Am Coll Cardiol. 2005; 45: 887–895.
15. Arom KV, Edwards JE. Relationship between right ventricular muscle bundles and pulmonary valve: significance in pulmonary atresia with intact ventricular septum. Circulation. 1976; 54 (6 suppl): III-79–III-83.[Medline]
16. Walmsley R. Anatomy of left ventricular outflow tract. Br Heart J. 1979; 41: 263–267.
17. Hasdemir C, Aktas S, Govsa F, Aktas EO, Kocak A, Bozkaya YT, Demirbas MI, Ulucan C, Ozdogan O, Kayikcioglu M, Can LH, Payzin S. Demonstration of ventricular myocardial extensions into the pulmonary artery and aorta beyond the ventriculo-arterial junction. Pacing Clin Electrophysiol. 2007; 30: 534–539.[CrossRef][Medline]
18. Talreja D, Gami AS, Edwards W, Friedman PA, Packer DL, Asirvatham SJ. The presence of ventricular muscular extensions into the pulmonary artery and aorta beyond the semilunar valves [abstract]. Pacing Clin Electrophysiol. 2001; 24: 734.[Medline]
19. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998; 339: 659–666.
20. Iwai S, Cantillon DJ, Kim RJ, Markowitz SM, Mittal S, Stein KM, Shah BK, Yarlagadda RK, Cheung JW, Tan VR, Lerman BB. Right and left ventricular outflow tract tachycardias: evidence for a common electrophysiologic mechanism. J Cardiovasc Electrophysiol. 2006; 17: 1052–1058.[CrossRef][Medline]
21. Dixit S, Lin D, Marchlinski FE. Ablation of ventricular outflow tract tachycardias. In: Huang SKS, Wood M, eds. Catheter Ablation of Cardiac Arrhythmias. Philadelphia, PA: Saunders Elsevier; 2006: 473–490.
22. Gepstein L, Hayam G, Ben-Haim SA. A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart: in vitro and in vivo accuracy results. Circulation. 1997; 95: 1611–1622.
23. Friedman P, Asirvatham S, Grice S, Glikson M, Munger T, Rea R, Shen W, Jahangir A, Packer D, Hammill S. Noncontact mapping to guide ablation of right ventricular outflow tract tachycardia. J Am Coll Cardiol. 2002; 39: 1808–1812.
24. Webb S, Qayyum SR, Anderson RH, Lamers WH, Richardson MK. Septation and separation within the outflow tract of the developing heart. J Anat. 2003; 202: 327–342.[Medline]
| Footnotes |
|---|
This article has been cited by other articles:
![]() |
N. Tabatabaei and S. J. Asirvatham Supravalvular Arrhythmia: Identifying and Ablating the Substrate Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 316 - 326. [Full Text] [PDF] |
||||
![]() |
E. M. Aliot, W. G. Stevenson, J. M. Almendral-Garrote, F. Bogun, C. H. Calkins, E. Delacretaz, P. D. Bella, G. Hindricks, P. Jais, M. E. Josephson, et al. EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Europace, June 1, 2009; 11(6): 771 - 817. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Home | Subscriptions | Archives | Feedback | Authors | Help | Circulation Journals Home | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |